SENATE 765118th CongressRead twice and referred to the Committee on Finance.
Reducing Hereditary Cancer Act of 2023
- Last Action
- 3/9/2023
Actions
- 2023-03-09Read twice and referred to the Committee on Finance.
- 2023-03-09Introduced in Senate
CRS Summary
As of 2023-03-09 (00)
Reducing Hereditary Cancer Act of 2023
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Cosponsors (2)
- Ben Cardin (D-MD)
- Gary Peters (D-MI)
Subjects
- Cancer
- Genetics
- Health care coverage and access
- Health promotion and preventive care
- Hereditary and development disorders
- Medical tests and diagnostic methods
- Medicare
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.